yingweiwo

Peptides

Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.

Peptides related products

Structure Cat No. Product Name CAS No. Product Description
LHRH (1-6) amide V35588 LHRH (1-6) amide 37783-55-4 LHRH (1-6) amide is a peptide compound.
LHRH (3-10) V35589 LHRH (3-10) 38280-52-3 LHRH (3-10) is a peptide compound.
LL-37 V36547 LL-37 597562-32-8 LL-37 amide is a positively charged antimicrobial peptide.
LQVTDSGLYRCVIYHPP TFA V60003 LQVTDSGLYRCVIYHPP TFA LQVTDSGLYRCVIYHPP (LP17) TFA is a myeloid cell-expressed triggering receptor 1 (TREM-1) inhibitory peptide.
Luteinizing Hormone-Releasing Hormone Antagonist V36553 Luteinizing Hormone-Releasing Hormone Antagonist Luteinizing Hormone-Releasing Hormone Antagonist is a peptide compound.
Lys-(Ala3)-Bradykinin V34928 Lys-(Ala3)-Bradykinin 103545-18-2 Lys-(Ala3)-Bradykinin is a peptide compound.
Lys-(Des-Arg9)-Bradykinin V34929 Lys-(Des-Arg9)-Bradykinin 71800-36-7 Lys-[Des-Arg9]Bradykinin is a naturally occurring kinin that is a potent and selective bradykinin B1 receptor agonist (activator) with Ki of B1 receptors in humans, mice and rabbits.
Lys-(Des-Arg9,Leu8)-Bradykinin V34930 Lys-(Des-Arg9,Leu8)-Bradykinin 71800-37-8 Lys-(Des-Arg9,Leu8)-Bradykinin is a bradykinin B1 receptor blocker (antagonist).
Lys-Bradykinin V34927 Lys-Bradykinin 342-10-9 Lys-Bradykinin is Kinin and bradykinin receptor ligand generated by enzymatic cleavage of kininogen protein by the protease kallikrein.
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) V36522 Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) 172615-51-9 IGF1Rtide can be used as a RET kinase substrate for RET kinase assays.
Macrophage Inhibitory Peptide V35590 Macrophage Inhibitory Peptide 41961-56-2 Macrophage Inhibitory Peptide is a peptide compound.
MAGE-1 Antigen (161-169) (human) V36576 MAGE-1 Antigen (161-169) (human) 144449-86-5 MAGE-1 Antigen (161-169) (human) is a peptide compound.
MAGE-3 Antigen (167-176) (human) V36577 MAGE-3 Antigen (167-176) (human) 178243-46-4 MAGE-3 Antigen (167-176) is a polypeptide containing 8 amino acid (AA)s.
MAGE-3 Antigen (168-176) (human) V36578 MAGE-3 Antigen (168-176) (human) 154652-68-3 MAGE-3 Antigen (168-176) (human) is a peptide compound.
MAGE-3 Antigen (271-279) (human) V36579 MAGE-3 Antigen (271-279) (human) 160295-81-8 MAGE-3 (271-279) is a short peptide with the sequence 271-279 of the melanoma antigen encoded by MAGE-3.
MAP17 (Cell-penetrating peptide MAP17) V85762 MAP17 (Cell-penetrating peptide MAP17) 1613241-14-7
MAPKK2 (1-16) (human, mouse, rat) V36929 MAPKK2 (1-16) (human, mouse, rat) MAPKK2 (1-16) (human, mouse, rat) is a peptide compound.
MARCKS Protein (151-175) V35591 MARCKS Protein (151-175) 134248-85-4 MARCKS Protein (151-175) is a peptide compound.
MART-1 (27-35) (human))|Melanoma-associated antigen peptide: MART-1(27-35),human V36556 MART-1 (27-35) (human))|Melanoma-associated antigen peptide: MART-1(27-35),human 156251-11-5 MART-1 (27-35) (human) is an immunogenic epitope recognized by tumor-infiltrating lymphocytes (TIL) specific for HLA-A2-restricted melanoma.
Mast Cell Degranulating (MCD) Peptide HR-1 V36557 Mast Cell Degranulating (MCD) Peptide HR-1 80533-94-4 HR1 is a papillary protease.
Contact Us